Publications

January 12th, 2009

English Editions of Urology (House Office Series)

urolbk1urolbk2urolbk3urolbk4ed

Foreign Language Versions

urolbkchin2urolbkchinese1_1urolbkpolish

Forward to the First Edition of Urology for the House Officer (1988)

 

The field of urology has expanded rapidly during the past decade, and as new findings in the laboratory and in clinical research are brought into the realm of standard practice, the body of information promises to increase even more rapidly.  Faced with this deluge of information, the new urology house officer must find innovative methods to evaluate and manage the spectrum of urologic problems with which he or she is faced on a daily basis.  The enormous daily work load of the house officer precludes extensive daily library searches or reading sessions and too often only a small portion of available knowledge is brought to bear on the multitude of clinical urology problems.  Though a plethora of texts and journals has emerged in recent years, none effectively addresses the issue of quick reference for the novice in urology.  Herein lies the great strength of this publication.

This book is divided into two major sections, Chief Presentations and Selected Topics.  In the first section, almost every possible clinical situation that can be encountered by the house officer is outlined.  This provides a quick reference to guide the physician in evaluating the patient and scheduling the necessary clinical and laboratory tests.  The section on Selected Topics is an in-depth but brief discussion of urologic diseases, including their management.  Useful tests and drugs along with the appropriate dosages and their potential toxicities are included.  The discussions on management, unencumbered by lengthy referencing and detailed discussion of current debates and controversies, provides a balanced final analysis of the state of the art.  The text is directed toward the more junior urology house officers, but is well suited to medical students at all levels during their clinical rotations in urology. Indeed, physicians in other specialties, especially Family Practice and Internal Medicine, will undoubtedly be rewarded by this text, out of proportion to the small amount of time needed to extract the ready information required to manage their patients.  The author is an energetic and talented urology house officer, who understands what students and junior house officers need to know.  I am sure that Urology for the House Officer will become the gold standard of a whole genre of such publications.

 

Jean B. deKernion M.D.

Professor of Surgery/Urology

Chief, Division of Urology

UCLA School of Medicine

Los Angeles, California

 

 

 

Abstracts/Presentations

 

  • 1. Macfarlane, MT: Detection of ras p21 in Serum of Patients with Urologic Malignancies Using Enzyme Linked Immunosorbent Assay. Western Section, AUA, Annual Meeting, February, 1987.
  • 2. Macfarlane, MT: Renal Cell Carcinoma Presenting as Lower Extremity Thrombophlebitis: Four Cases and a Review of the Literature. Western Section, AUA, Annual Meeting, February, 1987.
  • 3. Macfarlane, MT: Quantitative Expression of ras p21 in Voided Urines and Serum of Patients with Urologic Malignancies. Los Angeles Urological Society, Annual Residents Program, June, 1987.
  • 4. Macfarlane, MT: The Effects of Ischemia on Cadaveric Renal Transplants Receiving Cyclosporine. American Urological Association Annual Meeting, Boston, MA., June, 1988.
  • 5. Macfarlane, MT: The Role of Transrectal Ultrasound in Screening for Prostate Cancer. State of the Art in Urology, UCLA Extension, January, 1990.
  • 6. Macfarlane, MT: Early Detection of Prostate Cancer. Las Vegas Urological Society Meeting, Las Vegas, Nevada, June, 1990.
  • 7. Macfarlane, MT: Prostate Cancer Update. Centinella Hospital Medical Conference, Los Angeles, California, July, 1990.
  • 8. Macfarlane, MT: New Treatment Options in Prostate Cancer: Downstaging locally advanced disease. Long Beach Veterans Administration Medical Center, Oncology Grand Rounds, Long Beach, California, November, 1990.
  • 9. Macfarlane, MT: Prostate Specific Antigen. Tarzana Regional Medical Center, Medical Staff Conference, Tarzana, California. October, 1991.
  • 10. Macfarlane, MT: Screening for Prostate Cancer. Member of faculty for course entitled “Applications of Prostate Ultrasound in Benign and Malignant Disease” Century Plaza Hotel, Los Angeles, California. November 9-10, 1991.
  • 11. Macfarlane, MT: American College of Surgeons, Southern California Chapter. Chairman of Urology Section Annual Meeting. 1991-1992.
  • 12. Catalona, WJ, Richie, JP, Ahmann, FR, Hudson, MA, Scardino, PT, Flanigan, RC, deKernion, JB, Ratliff, TL, Kavoussi, LR, Dalkin, BL, Waters, WB, Macfarlane, MT, Southwick, PC: A multicenter evaluation of PSA and digital rectal examination (DRE) for early detection of prostate cancer in 6,374 volunteers. J Urol 1993; 149 (suppl): 412.
  • 13. Richie, JP, Catalona, WJ, Ahmann, FR, Hudson, MA, Scardino, PT, Flanigan, RC, deKernion, JB, Ratliff, TL, Kavoussi, LR, Dalkin, BL, Waters, WB, Macfarlane, MT, Southwick, PC: Patient age and the effectiveness of PSA and digital rectal examination (DRE) for early detection of prostate cancer. J Urol 1993; 149 (suppl): 413.
  • 14. Flanigan, RC, Catalona, WJ, Richie, JP, Ahmann, FR, Hudson, MA, Scardino, PT, deKernion, JB, Ratliff, TL, Kavoussi, LR, Dalkin, BL, Waters, WB, Macfarlane, MT, Southwick, PC: Success rate of digital rectal examination (DRE) and transrectal ultrasonography (TRUS) in localizing prostate cancer. J Urol 1993; 149 (suppl): 288.
  • 15. Southwick,, PC, Catalona, WJ, Richie, JP, Ahmann, FR, Hudson, MA, Scardino, PT, Flanigan, RC, deKernion, JB, Ratliff, TL, Kavoussi, LR, Dalkin, BL, Waters, WB, Macfarlane, MT: Evaluation of prostate specific antigen (PSA) and digital rectal examination (DRE) for early detection of prostate cancer: Results of a multicenter study of 6,630 men. Clin Chem 1993; 39 (suppl): 1195.
  • 16. Richie, JP, Catalona, WJ, Ahmann, FR, Hudson, MA, Scardino, PT, Flanigan, RC, deKernion, JB, Ratliff, TL, Kavoussi, LR, Dalkin, BL, Waters, WB, Macfarlane, MT, Southwick, PC: Prostate cancer screening: Impact of digital rectal examination, prostate specific antigen and age of patient in multicenter clinical trial of 6,630 men. Amer College of Surgeons, October 1993, San Francisco, California.
  • 17. Catalona, WJ, Hudson, MA, Scardino, PT, Richie, JP, Ahmann, FR, Flanigan, RC, deKernion, JB, Ratliff, TL, Kavoussi, LR, Dalkin, BL, Waters, WB, Macfarlane, MT, Southwick, PC: Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: Receiver operating characteristic curves. J Urol 1994; 151 (suppl): 449.
  • 18. Richie, JP, Catalona, WJ, deKernion, JB, Ahmann, FR, Ratliff, TL, Dalkin, BL, Kavoussi, LR, Macfarlane, MT, Southwick, PC: Evaluation of prostate specific antigen (PSA) versus PSA density (PSAD) in the early detection of prostate cancer: Results of a prospective multicenter clinical trial of 4,962 men. J Urol 1994; 151 (suppl): 303.
  • 19. Catalona, WJ, Hudson, MA, Scardino, PT, Richie, JP, Ahmann, FR, Flanigan, RC, deKernion, JB, Ratliff, TL, Kavoussi, LR, Dalkin, BL, Waters, WB, Macfarlane, MT, Southwick, PC: Selection of optimal prostate specific antigen cutoffs for early detection of prostate cancer: Receiver operating characteristic curves. GU Surg 1994; (108th Meeting).
  • 20. Richie, JP, Catalona, WJ, deKernion, JB, Ahmann, FR, Ratliff, TL, Dalkin, BL, Kavoussi, LR, Macfarlane, MT, Southwick, PC. Evaluation of prostate specific antigen (PSA) versus PSA density (PSAD) in the early detection of prostate cancer: Results of a prospective multicenter clinical trial of 4,962 men. GU Surg 1994; (108th Meeting).

Journal Articles

  • 1. Krisiloff, M, Puchner, PJ, Tretter, W, Macfarlane, MT, and Lattimer, JK: Pregnancy in Women with Bladder Exstrophy. J. Urol., 119:478, April 1978.
  • 2. Lattimer, JK, Beck, L, Yeaw, S, Puchner, PJ, Macfarlane, MT and Krisiloff, M: Long-Term Follow-up After Exstrophy Closure: Late Improvement and Good Quality of Life. J. Urol., 119:664, May,1978.
  • 3. Lattimer, JK, Macfarlane, MT, and Puchner, PJ: Male Exstrophy Patients: A Preliminary Report on the Reproductive Capability. Transactions of the American Association of Genito-Urinary Surgeons. 68, 1978.
  • 4. Lattimer, JK, Puchner, PJ, Hensle, TW and Macfarlane, MT: Delayed Development of the Scrotum in Exstrophy. J. Urol., 121:339, March, 1979.
  • 5. Lattimer, JK, Hensle, TW, Macfarlane, MT, Beck, L, Zweighaft, M, Braun, E and Esposito, Y: The Exstrophy Support Team - A New Concept in the Care of the Exstrophy Patient. J. Urol., 121:472, April, 1979.
  • 6. Macfarlane, MT, Lattimer, JK and Hensle, TW: Improved Life Expectancy for Children with Exstrophy of the Bladder. JAMA, 242:442-444, 1979.
  • 7. Macfarlane, MT, Lattimer, JK and Hensle, TW: The Unheralded Hazard of Ureterosigmoidostomy. Pediatrics, 64:668-671, November, 1979.
  • 8. Lattimer, JK and Macfarlane, MT: A Urethral Lengthening Procedure for Epispadias and Exstrophy. J. Urol., 123:544, April, 1980.
  • 9. Maloney, WJ, Macfarlane, MT, and Rimsza, MF: Methemoglobinemia in an infant. Arizona Medicine, 40:700-2, 1983.
  • 10. Koyle, MA, Macfarlane, MT, Rosen, M, Gritsch, HA, Sender, MB, Rajfer, J, Glassock, RJ, and Ward, HJ: Prolonged cold storage and the cadaveric kidney transplant recipient. Trans. Proc. 21:1283-4, 1989.
  • 11. Macfarlane, MT, Stein, A, Layfield, L and deKernion, JB: Preoperative endoscopic diagnosis of fibroepithelial polyp of the renal pelvis: A case report and review of the literature. J. Urol., 145:549-551, 1991.
  • 12. Macfarlane, MT: Epitomes: Screening for Prostate Cancer. Western J. Med., 1991.
  • 13. Abi-Aad, AS, Macfarlane, MT, Stein, A, and deKernion, JB: Detection of local recurrence after radical prostatectomy by prostate specific antigen and transrectal ultrasound. J. Urol., 147:952-955, 1992.
  • 14. Macfarlane, MT, Abi-Aad, A, Stein, A, Danella, J, Belldegrun, A, and deKernion, JB: Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer. J Urol., 150:132-134, 1993.
  • 15. Richie, JP, Catalona, WJ, Ahmann, FR, Hudson, MA, Scardino, PT, Flanigan, RC, deKernion, JB, Ratliff, TL, Kavoussi, LR, Dalkin, BL, Waters, WB, Macfarlane, MT, Southwick, PC: Effect of patient age on early detection of prostate cancer with serum prostate specific antigen and digital rectal examination. Urology, 42:365-374, 1993.
  • 16. Catalona, WJ, Richie, JP, Ahmann, FR, Hudson, JA, Scardino, PT, Flanigan, RC, deKernion, JB, Ratliff, TL, Kavoussi, LR, Dalkin, BL, Waters, WB, Macfarlane, MT, Southwick, PC: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. J Urol., 151:1283-1290, 1994.
  • 17. Flanigan, RC, Catalona, WJ, Richie, JP, Ahmann, FR, Hudson, MA, Scardino , PT, deKernion, JB, Ratliff, TL, Kavoussi, LR, Dalkin, BL, Waters, WB, Macfarlane, MT, Southwick, PC: Accuracy of digital rectal examination (DRE) and transrectal ultrasonography (TRUS) in localizing prostate cancer. J Urol., 152:1506-1509, 1994.
  • 18. Catalona, WJ, Hudson, MA, Scardino, PT, Richie, JP, Ahmann, FR, Flanigan, RC, deKernion, JB, Ratliff, TL, Kavoussi, LR, Dalkin, BL, Waters, WB, Macfarlane, MT, Southwick, PC: Selection of optimal prostate specific antigen (PSA) cutoffs for early detection of prostate cancer: Receiver operating characteristic (ROC) curves. J Urol., 152:2037-2042, 1994.
  • 19. Catalona, WJ, Richie, JP, deKernion, JB, Ahmann, FR, Ratliff, TL, Dalkin, BL, Kavoussi, LR, Macfarlane, MT, Southwick, PC: Comparison of prostate specific antigen (PSA) concentration versus prostate specific antigen density (PSAD) in the early detection of prostate cancer: Receiver operating characteristic (ROC) curves. J Urol., 152:2031-2036, 1994.
  • 20. Dalkin, BL, Ahmann, FR, Kopp, JB, Catalona, WJ, Ratliff, TL, Hudson, MA, Richie, JP, Scardino, PT, Flanigan, RC, Dekernion, JB, Waters, WB, Kavoussi, LR, Macfarlane, MT: Derivation and application of upper limits for prostate specific antigen in men aged 50-74 years with no clinical evidence of prostatic carcinoma. Brit. Jour. of Urol. 76:346-350, 1995.
  • 21. Macfarlane, MT: Consequences of health care reform. Louisville Medicine, XLI(11):4, 1994.
  • 22. Macfarlane, MT: Generalists vs. Specialists. Louisville Medicine, XLII(4):4, 1994.
  • 23. Macfarlane, MT: Clinical guidelines. Louisville Medicine, XLII(6):34, 1994.
  • 24. Macfarlane, MT: Physicians need one standard contract. Louisville Medicine, XLII(8):4, 1994.
  • 25. Macfarlane, MT: Do doctors really make too much?, Louisville Medicine, XLII(10):25, 1994
  • 26. Macfarlane, MT: Steps can be taken to fight prostate cancer. Business First, July 11, 1994.
  • 27. Macfarlane, MT: Should helath services be the responsibility of schools? NO. Louisville Medicine, XLIII (4), 1995.
  • 28. Macfarlane, MT: Should we screen for prostate cancer? Louisville Medicine, XLIII,(1), 1995.
  • 29. Macfarlane, MT: Editors commentary: Ethics of capitation. Louisville Medicine, Vol. 56, (9), 1996.
  • 30. Macfarlane, MT: Editor’s Note: Getting Louisville Medicine in shape. Louisville Medicine, XLIII (8), 1996.
  • 31. Macfarlane, MT: Managed Care (commentary). Louisville Medicine, Vol 45, (2), 1997.
  • 32. Macfarlane, MT: What can we do to improve HMO executive compensation? Louisville Medicine, Vol 45, No.4, 1997.
  • 33. Macfarlane, MT: Should patients be able to sue their HMOs? Louisville Medicine, Vol 46, No. 4 Sept. 1998.
  • 34. Macfarlane, MT: Going Paperless - EMR Part I (Transitioning to Electronic Medical Records). Louisville Medicine, Vol 54, No.10 March, 2007.
  • 35. Macfarlane, MT: Going Paperless - EMR Part II (Medical Information Technology). Louisville Medicine, Vol 54, No. 11 April, 2007.

Book Chapters

  • 1. Macfarlane, MT, Koyle, MA, and Ehrlich, RM: Wilms’ Tumor. In Lytton, B (ed): Advances in Urology. Chicago, Year Book Medical Publishers, 1989.
  • 2. Macfarlane, MT, Smith, RB: Management of vascular complications in urologic surgery. In Smith, RB and Ehrlich, RM (eds): Complications in Urologic Surgery: Prevention and Management, ed 2. Philadelphia, W.B. Saunders, 1989.
  • 3. Macfarlane, MT and Ehrlich, RE: Pediatric tumors: An overview. In Crawford, ED, and Das, S (eds): Current Genitourinary Cancer Surgery. Philadelphia, Lea & Febiger, 1989.
  • 4. Macfarlane, MT, deKernion, JB, and Figlin, R: Neoplasms of the genitourinary tract: Neoplasms of the bladder and urethra. In Cancer Medicine, 3rd ed, 1992.
  • 5. Macfarlane, MT, Smith, RB: Management of vascular complications in urologic surgery. In Taneja, SS, Smith, RB and Ehrlich, RM (eds): Complications in Urologic Surgery: Prevention and Management, 3rd Edition. Philadelphia, W.B. Saunders, 2000.

Books

  • 1. Macfarlane, MT: Urology for the House Officer. Baltimore, Williams & Wilkins Co. 1988.
  • 2. Macfarlane, MT: Urology, Second Edition (House Officer Series), Baltimore, Williams
  • 1. & Wilkins Co. 1995.
  • 2. Macfarlane, MT: Urology, Second Edition (House Officer Series), Baltimore, Williams & Wilkins Co. 1995 (Japanese Language Edition).
  • 3. Macfarlane, MT: Urologia, Urban & Partner, 1996 (Polish Language Edition).
  • 4. Macfarlane, MT: Urology, Philadelphia, Lippincott Williams & Wilkins, 2001 (Chinese Language Edition).
  • 5. Macfarlane, MT: Urology, Third Edition (House Officer Series), Philadelphia, Lippincott Williams & Wilkins, 2001
  • 6. Macfarlane, MT: Urology, Fourth Edition (House Officer Series), Philadelphia, Lippincott Williams & Wilkins, 2006

Monographs

  • 1. Macfarlane, MT: Recent Advances in the Treatment of Benign Prostatic Hyperplasia: Prevalence, Etiology and Pathophysiology, 1990.

Videos

  • 1. Macfarlane, MT (content leader), McConnel, J, Soloway, M, Trieger, B, and Marks, L: Update on Benign Prostatic Hyperplasia for the Family Practitioner. UCLA Extension, 1992.
  • 2. Macfarlane, MT (content leader), McConnel, J, Soloway, M, Trieger, B, and Marks, L: Update on Benign Prostatic Hyperplasia for the Urologist. UCLA Extension, 1992.

Exhibits

  • 1. Macfarlane, MT, Lattimer, JK, Hensle, TW and Puchner, PJ: Exstrophy - The Improved Prognosis in Modern Times. Received the Wirt B. Dakin Historical Exhibit Award, Annual Meeting of the American Urological Association, May, 1979, New York, New York,
  • 2. Macfarlane, MT, deKernion, JB, Brosman, SA, Dorey, F, Koo, A, and Liu, BCS: Expression of ras Oncogene p21 in Voided Urines and Serum of Patients with Urologic Cancers. AUA Annual Meeting, 1987, Anaheim, CA.
Comments are closed.